Internal Deadlines, Drug Approvals, and Safety Problems
Year of publication: |
November 2020
|
---|---|
Authors: | Cohen, Lauren |
Other Persons: | Gurun, Umit (contributor) ; Li, Danielle (contributor) |
Institutions: | National Bureau of Economic Research (contributor) |
Publisher: |
2020: Cambridge, Mass : National Bureau of Economic Research |
Subject: | Arzneimittel | Pharmaceuticals | Arzneimittelrecht | Pharmaceutical law |
Extent: | 1 Online-Ressource illustrations (black and white) |
---|---|
Series: | NBER working paper series ; no. w28071 |
Type of publication: | Book / Working Paper |
Language: | English |
Notes: | System requirements: Adobe [Acrobat] Reader required for PDF files Mode of access: World Wide Web Hardcopy version available to institutional subscribers |
Other identifiers: | 10.3386/w28071 [DOI] |
Source: | ECONIS - Online Catalogue of the ZBW |
-
Reverse drug distribution chain : analysis of the phenomenon
Bańska, Karolina, (2022)
-
Bargaining and international reference pricing in the pharmaceutical industry
Dubois, Pierre, (2022)
-
Brunko, Patricia, (1994)
- More ...
-
Don’t Take Their Word For It : The Misclassification of Bond Mutual Funds
Chen, Huaizhi, (2019)
-
IQ from IP : Simplifying Search in Portfolio Choice
Chen, Huaizhi, (2018)
-
Patent Trolls : Evidence from Targeted Firms
Cohen, Lauren, (2014)
- More ...